Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators

American Journal of Cardiology

Volumn 92, Issue 1, 2003, Pages 26-32

  Kouakam, Claude ^a   Lauwerier, Bénédicte ^a   Klug, Didier ^a   Jarwe, Moustapha ^a   Marquié, Christelle ^a   Lacroix, Dominique ^a   Kacet, Salem ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS TACHYCARDIA; SYMPATHETIC TONE; TREATMENT OUTCOME;

EID: 0038538316     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00459-4     Document Type: Article

References (30)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
2. Leitch J.W., Gillis A.M., Wyse D.G., Yee R., Klein G.J., Guiraudon G., Sheldon R.S., Duff H.J., Kieser T.M., Mitchell L.B. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol. 18:1991;145-151.
3. Fromer M., Brachmann J., Block M., Siebels J., Hoffmann E., Almendral J., Ohm O.J., den Dulk K., Coumel P., Camm A.J. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Circulation. 86:1992;363-374.
4. Heisel A., Neuzner J., Himmrich E., Pitschner H.F., Liebrich A., Jung J., Sen S. Safety of antitachycardia pacing in patients with implantable cardioverter defibrillator and severely depressed left ventricular function. PACE. 18:1995;137-141.
5. Moss A.J., Hall J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 335:1996;1933-19401.
6. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 341:1999;1882-1890.
7. Sears S.F. Jr, Todaro J.F., Lewis T.S., Sotile W., Conti J.B. Examining the psychological impact of implantable cardioverter defibrillators a literature review . Clin Cardiol. 22:1999;481-489.
8. Calkins H., El-Atassi R., Kalbfleisch S., Langberg J., Morady F. Comparison of fixed burst versus decremental burst pacing for termination of ventricular tachycardia. PACE. 16:1993;26-32.
9. Newman D., Dorian P., Hardy J. Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol. 21:1993;1413-1418.
10. Wood M.A., Stambler B.S., Damiano R.J., Greenway P., Ellenbogen K.A. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. J Am Coll Cardiol. 24:1994;1692-1699.
11. Rosenqvist M. Antitachycardia pacing Which patients and which methods? Am J Cardiol. 78:(suppl 5A):1996;92-97.
12. Nazir N. Jr, Pacifico A., Doyle T.K., Earle N.R., Hardage M.L., Henry P.D. Spontaneous ventricular tachycardia treated by antitachycardia pacing. Am J Cardiol. 79:1997;820-822.
13. Fries R., Heisel A., Kalweit G., Jung J., Schieffer H. Antitachycardia pacing in patients with implantable cardioverter defibrillators how many attempts are useful? PACE. 20:1997;198-202.
14. Peinado R., Almendral J.M., Rius T., Moya A., Merino J.L., Martinez-Alday J., Perez-Villacastin J., Arenal A., Ormaetxe J., Tercedor L., et al. Randomized, prospective comparison of four bursts pacing algorithms for spontaneous ventricular tachycardia. Am J Cardiol. 82:1998;1422-1425.
15. Schaumann A., von zur Mühlen F., Herse B., Gonska B.D., Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators. A prospective study including 200 patients. Circulation. 97:1998;66-74.
16. Wathen M.S., Sweeney M.O., DeGroot P.J., Stark A.J., Koehler J.L., Chisner M.B., Machado C., Adkisson W.O. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. 104:2001;796-801.
17. Le Franc P., Klug D., Jarwe M., Lacroix D., Delfaut P., Kouakam C., Kacet S. Extraction of endocardial implantable cardioverter-defibrillator leads. Am J Cardiol. 84:1999;187-191.
18. Schaumann A., von zur Mühlen F., Gonska B.D., Kreuzer H. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiol. 78:1996;42-50.
19. Seidl K., Hauer B., Schwick N.G., Zahn R., Senges J. Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol. 82:1998;744-748.
20. Korte T., Jung W., Ostermann G., Wolpert C., Spehl S., Esmailzadeh B., Luderitz B. Hospital readmission after transvenous cardioverter defibrillator implantation. A single center study. Eur Heart J. 21:2000;1186-1191.
21. Binah O., Rosen M.R. Mechanisms of ventricular arrhythmias. Circulation. 85:(suppl I):1992;125-131.
22. El-Sherif N. Electrophysiologic mechanisms in electrical therapy of ventricular tachycardia. Saksena S., Goldschlager N. Electrical Therapy for Cardiac Arrhythmias. 1990;395-410 WB Saunders, Philadelphia, PA.
23. Fischer J., Mehra R., Furman S. Termination of ventricular tachycardia with bursts of rapid ventricular pacing. Am J Cardiol. 11:1978;91-107.
24. Constantin L., Martins J.B. Autonomic control of ventricular tachycardia direct effects of beta-adrenergic blockade in 24 hour old canine myocardial infarction . J Am Coll Cardiol. 9:1987;366-373.
25. Olshansky B., Martins J.B. Usefulness of isoproterenol facilitation of ventricular tachycardia induction during extrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade. Am J Cardiol. 59:1987;573-577.
26. Wiesfeld A.C., Crijns H.J., Tuininga Y.S., Lie K.I. Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. PACE. 19:1996;1026-1035.
27. Porterfield J., Porterfield L., Smith B.A., Bray L., Voshage L., Martinez A. Conversion rates of induced and spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. PACE. 16:1993;170-173.
28. Pruvot E., Thonet G., Vesin J.M., van-Melle G., Seidl K., Schmidinger H., Brachmann J., Jung W., Hoffmann E., Tavernier R., et al. Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation. 101:2000;2398-2404.
29. Hammill S.C., Packer D.L., Stanton M.S., Fetter J.S. Termination and acceleration of ventricular tachycardia with autodecremental pacing burst pacing and cardioversion in patients with an implantable cardioverter defibrillator. PACE. 18:1995;3-10.
30. Muratore C., Rabinovick R., Iglesias R., Gonzalez M., Daru V., Liprandi A.S. Implantable cardioverter defibrillators in patients with Chagas' disease are they different from patients with coronary disease? PACE. 20:1997;194-197.